TP53 and Duchenne muscular dystrophy: Beyond the aforementioned two diseases, disorders caused by genetic mutations—such as peroxisome biogenesis disorders (PBDs) [21], Duchenne muscular dystrophy (DMD) [104,105], Rett syndrome [106], and mutations in the TP53 tumor suppressor gene [49]—are also potential candidates for treatment with A-to-I and U-to-Ψ editing.